Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

199
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
199
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

464
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
464
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

295
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
295
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

156
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
156
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

443
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
443
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

341
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
341

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice.

Science advances·2026
Same author

Cell Envelope Remodeling and Lipid Metabolism Coordinate Extracellular Vesicle Output in Mycobacterium Tuberculosis.

Journal of extracellular biology·2026
Same author

Commensal-derived acetylcholine enhances mucosal immune education.

Nature·2026
Same author

Case Report: Nasal acinic cell carcinoma in a cat: clinicopathological and immunohistochemical characterization of a rare neoplasm.

Frontiers in veterinary science·2026
Same author

Pulmonary Surfactant Nanoparticles for Lung-Targeted and Dose-Efficient Delivery.

Advanced healthcare materials·2026
Same author

Standardizing tear proteomics preanalytics: Capillary vs Schirmer sampling and denaturing vs mild elution buffers shape proteome depth and abundance profiles.

Journal of proteomics·2026

相关实验视频

Updated: Jul 14, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

19.6K

线粒体功能障碍促进微生物组成,对性结肠炎的发展和进展产生负面影响.

Ainize Peña-Cearra1,2,3, Deguang Song4, Janire Castelo1

  • 1CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park Bld 801 A, 48160, Derio, Spain.

NPJ biofilms and microbiomes
|October 7, 2023
PubMed
概括

缺乏线粒体蛋白MCJ的小鼠肠道微生物群的改变增加了对炎症性肠病 (IBD) 的易感性. 便微生物群移植 (FMT) 逆转了这种易感性,突出了微生物在IBD病变发生中的作用.

更多相关视频

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.3K

相关实验视频

Last Updated: Jul 14, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

19.6K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.3K

科学领域:

  • 线粒体生物学 线粒体生物学
  • 肠道微生物组研究研究
  • 炎症性肠病 (IBD) 的病原体是什么?

背景情况:

  • 线粒体功能障碍与IBD有关.
  • 缺乏MCJ的小鼠对DSS结肠炎的易感性增加.
  • 在这种表型中,肠道微生物群与MCJ缺乏的作用尚不清楚.

研究的目的:

  • 为了研究肠道微生物群在MCJ缺陷相关性结肠炎中的作用.
  • 探索MCJ缺乏对蛋白质表达通路的影响.
  • 在MCJ缺乏的小鼠中识别微生物特征和IgA涂层.

主要方法:

  • 便微生物群移植 (FMT) 进入没有细菌的小鼠.
  • 共同住房实验改变微生物群组成.
  • 磁激活细胞分类 (MACS) 和16S rRNA基因测序用于IGA-SEQ.
  • 蛋白质表达通路的分析.

主要成果:

  • 来自MCJ缺乏的小鼠的FMT给无细菌的接受者赋予了结肠炎的易感性.
  • MCJ 缺陷会影响与IBD相关的蛋白质表达通路.
  • 在MCJ缺乏的小鼠中观察到便细菌的高IgA涂层,与疾病进展相关.
  • 确定了与I复合体缺乏和疾病进展相关的微生物特征.

结论:

  • 肠道微生物群失生症在MCJ缺陷驱动的IBD易感性中发挥着关键作用.
  • 缺少MCJ会影响宿主微生物的相互作用,包括IgA涂层.
  • 识别微生物生物标志物可能有助于对性结肠炎 (UC) 患者进行分层.